India may come up with a vaccine against tuberculosis two years down the line, with the phase-3 clinical trials of two candidates set to conclude in 2024.

Dr Suchit Kamble, a scientist at the ICMR-National AIDS Research Institute (NARI) in Pune, informed that the trials are underway to evaluate the efficacy and safety of two TB vaccine candidates -- VPM1002 and Immunovac -- in preventing tuberculosis in healthy household contacts of newly-diagnosed sputum positive pulmonary TB patients.